SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023990
Filing Date
2023-07-07
Accepted
2023-07-07 16:17:08
Documents
14
Period of Report
2023-07-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40368
2 ex10-1.htm EX-10.1 18825
3 ex10-2.htm EX-10.2 16088
  Complete submission text file 0001493152-23-023990.txt   259421

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE invo-20230707.xsd EX-101.SCH 3033
5 XBRL LABEL FILE invo-20230707_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE invo-20230707_pre.xml EX-101.PRE 22801
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3355
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39701 | Film No.: 231076983
SIC: 3841 Surgical & Medical Instruments & Apparatus